Apply Give

Other ways to search: Events Calendar | UTHSC

UTHSC’s Athena Starlard-Davenport awarded NIH grant to study potential sickle cell treatment pathway

Written by Communications and Marketing

|

In a century’s worth of drug approvals, only four sickle cell disease treatments have received Food and Drug Administration (FDA) approval. A University of Tennessee Health Science Center (UTHSC) researcher hopes her work will help increase that number. Athena Starlard-Davenport, Ph.D., was awarded a three-year, $900,000-plus National Institutes of Health (NIH) grant to serve as principal investigator on the project titled “MicroRNA-based epigenetic approach to induce fetal hemoglobin.” This is her first national grant award.

Top Publishers